{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:53:07Z","timestamp":1791078787806,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T00:00:00Z","timestamp":1291248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Diseases"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:p><jats:italic>Oral Diseases<\/jats:italic>(2011)<jats:bold>17<\/jats:bold>, 427\u2013432<\/jats:p><jats:p><jats:bold>Objectives:\u2002<\/jats:bold>Bisphosphonates commonly used to treat osteoporosis, Paget\u2019s disease, multiple myeloma, hypercalcemia of malignancy and osteolytic lesions of cancer metastasis have been associated with bisphosphonate\u2010associated jaw osteonecrosis (BJON). The underlying pathogenesis of BJON is unclear, but disproportionate bisphosphonate concentration in the jaw has been proposed as one potential etiological factor. This study tested the hypothesis that skeletal biodistribution of intravenous bisphosphonate is anatomic site\u2010dependent in a rat model system.<\/jats:p><jats:p><jats:bold>Materials and Methods:\u2002<\/jats:bold>Fluorescently labeled pamidronate was injected intravenously in athymic rats of equal weights followed by<jats:italic>in vivo<\/jats:italic>whole body fluorimetry,<jats:italic>ex vivo<\/jats:italic>optical imaging of oral, axial, and appendicular bones and ethylenediaminetetraacetic acid bone decalcification to assess hydroxyapatite\u2010bound bisphosphonate.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Bisphosphonate uptake and bisphosphonate released per unit calcium were similar in oral and appendicular bones but lower than those in axial bones. Hydroxyapatite\u2010bound bisphosphonate liberated by sequential acid decalcification was the highest in oral, relative to axial and appendicular bones (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold>This study demonstrates regional differences in uptake and release of bisphosphonate from oral, axial, and appendicular bones of immune deficient rats.<\/jats:p>","DOI":"10.1111\/j.1601-0825.2010.01772.x","type":"journal-article","created":{"date-parts":[[2010,12,2]],"date-time":"2010-12-02T08:51:19Z","timestamp":1291279879000},"page":"427-432","source":"Crossref","is-referenced-by-count":51,"title":["Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate"],"prefix":"10.1111","volume":"17","author":[{"given":"D","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SO","family":"Akintoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,2]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000151371"},{"key":"e_1_2_6_3_1","first-page":"227","volume-title":"Does rat + bisphosphonate + exposed bone = an animal model of ONJ?","author":"Allen MR","year":"2009"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2008.01.038"},{"key":"e_1_2_6_5_1","first-page":"2200","article-title":"Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats","volume":"29","author":"Bauss F","year":"2002","journal-title":"J Rheumatol"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-007-0837-x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00061-2"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.19.1.0325"},{"key":"e_1_2_6_9_1","volume-title":"Bisphosphonates in bone disease: from the laboratory to the patient","author":"Fleisch H","year":"2000"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-008-0741-9"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00391.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ar.a.20396"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-008-9104-y"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02015393"},{"key":"e_1_2_6_15_1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0090-9556(25)08706-9","article-title":"Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats","volume":"20","author":"Lin JH","year":"1992","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.07.010"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21130"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70726-4"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2007.04.196"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118722"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033453640"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2006.06.004"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2007.01381.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115539"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2008.04.013"},{"key":"e_1_2_6_26_1","first-page":"430","article-title":"Effects of pamidronate on oro\u2010facial human bone marrow stromal cells","volume":"85","author":"Stefanik D","year":"2006","journal-title":"J Dent Res"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2007.01402.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-10-200605160-00009"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1201-1148"}],"container-title":["Oral Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1601-0825.2010.01772.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1601-0825.2010.01772.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T11:00:36Z","timestamp":1740740436000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1601-0825.2010.01772.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,2]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1601-0825.2010.01772.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01772.x","archive":["Portico"],"relation":{},"ISSN":["1354-523X","1601-0825"],"issn-type":[{"value":"1354-523X","type":"print"},{"value":"1601-0825","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,2]]}}}